Background: Intracerebral hemorrhage (ICH) remains a devastating neurological disorder with limited therapeutic options. Neural stem cell (NSC)-based therapies have emerged as a potential regenerative approach, yet the molecular mechanisms regulating NSC behavior require further elucidation. The role of miR-21 in NSC differentiation and proliferation during ICH recovery remains unexplored.
Methods: In vitro NSC cultures were analyzed for miR-21 expression dynamics during differentiation via qPCR. Lentiviral overexpression and knockdown of miR-21 were employed to assess its functional impact. The SOX2/LIN28-let-7 pathway was investigated using Western blot, luciferase reporter assays, and immunofluorescence. In vivo, miR-21-overexpressing NSCs were transplanted into a murine ICH model, with neurogenesis evaluated by immunostaining and neurological recovery assessed through behavioral tests (mNSS, rotarod).
Results: miR-21 expression significantly increased during NSC differentiation, correlating with reduced SOX2 levels. Mechanistically, miR-21 directly targeted SOX2, disrupting the SOX2/LIN28-let-7 axis to promote NSC proliferation and lineage commitment. In ICH mice, transplantation of miR-21-overexpressing NSCs enhanced neurogenesis and improved motor coordination and neurological deficits at 28 days post-transplantation.
Conclusions: Our findings identify miR-21 as a critical regulator of NSC plasticity through SOX2/LIN28-let-7 signaling, highlighting its therapeutic potential for enhancing neuroregeneration and functional recovery in ICH. Targeting miR-21 may represent a novel strategy to optimize NSC-based therapies for hemorrhagic stroke.
| [1] |
Broderick JP, Grotta JC, Naidech AM, et al. The story of intracerebral hemorrhage: from recalcitrant to treatable disease. Stroke. 2021;52(5):1905-1914.
|
| [2] |
Flaherty M, Haverbusch M, Sekar P, et al. Long-term mortality after intracerebral hemorrhage. Neurology. 2006;66(8):1182-1186.
|
| [3] |
Feigin VL, Lawes CM, Bennett DA, Barker-Collo SL, Parag V. Worldwide stroke incidence and early case fatality reported in 56 population-based studies: a systematic review. Lancet Neurol. 2009;8(4):355-369.
|
| [4] |
Kaminska A, Radoszkiewicz K, Rybkowska P, Wedzinska A, Sarnowska A. Interaction of neural stem cells (NSCs) and mesenchymal stem cells (MSCs) as a promising approach in brain study and nerve regeneration. Cells. 2022;11(9):1464.
|
| [5] |
Matsubara S, Matsuda T, Nakashima K. Regulation of adult mammalian neural stem cells and neurogenesis by cell extrinsic and intrinsic factors. Cells. 2021;10(5):1145.
|
| [6] |
Chen F, Zhang Z, Wang LN, et al. Transplantation of NEP1-40 and NT-3 gene-Co-transduced neural stem cells improves function and neurogenesis after spinal cord injury in a rat model. Neurol India. 2022;70(supplement):S251-S258.
|
| [7] |
Zhang GL, Zhu ZH, Wang YZ. Neural stem cell transplantation therapy for brain ischemic stroke: review and perspectives. World J Stem Cells. 2019;11(10):817-830.
|
| [8] |
Lee HJ, Lim IJ, Lee MC, Kim SU. Human neural stem cells genetically modified to overexpress brain-derived neurotrophic factor promote functional recovery and neuroprotection in a mouse stroke model. J Neurosci Res. 2010;88(15):3282-3294.
|
| [9] |
Lee HJ, Kim KS, Park IH, Kim SU. Human neural stem cells over-expressing VEGF provide neuroprotection, angiogenesis and functional recovery in mouse stroke model. PLoS One. 2007;2(1):e156.
|
| [10] |
Wakai T, Sakata H, Narasimhan P, Yoshioka H, Kinouchi H, Chan PH. Transplantation of neural stem cells that overexpress SOD1 enhances amelioration of intracerebral hemorrhage in mice. J Cereb Blood Flow Metab. 2014;34(3):441-449.
|
| [11] |
Valinezhad Orang A, Safaralizadeh R, Kazemzadeh-Bavili M. Mechanisms of miRNA-mediated gene regulation from common downregulation to mRNA-specific upregulation. Int J Genomics. 2014;2014(1):970607.
|
| [12] |
Zhang S, Cheng Z, Wang Y, Han T. The risks of miRNA therapeutics: in a drug target perspective. Drug Des Devel Ther. 2021;15:721-733.
|
| [13] |
Selbach M, Schwanhäusser B, Thierfelder N, Fang Z, Khanin R, Rajewsky N. Widespread changes in protein synthesis induced by microRNAs. Nature. 2008;455(7209):58-63.
|
| [14] |
Kloosterman WP, Plasterk RH. The diverse functions of microRNAs in animal development and disease. Dev Cell. 2006;11(4):441-450.
|
| [15] |
Wang J, Zhu Y, Jin F, Tang L, He Z, He Z. Differential expression of circulating microRNAs in blood and haematoma samples from patients with intracerebral haemorrhage. J Int Med Res. 2016;44(3):419-432.
|
| [16] |
Liu DZ, Tian Y, Ander BP, et al. Brain and blood microRNA expression profiling of ischemic stroke, intracerebral hemorrhage, and kainate seizures. J Cereb Blood Flow Metab. 2010;30(1):92-101.
|
| [17] |
Wang M, Mungur R, Lan P, Wang P, Wan S. MicroRNA-21 and microRNA-146a negatively regulate the secondary inflammatory response of microglia after intracerebral hemorrhage. Int J Clin Exp Pathol. 2018;11(7):3348.
|
| [18] |
Zhang WM, Zhang ZR, Yang XT, Zhang YG, Gao YS. Overexpression of miR-21 promotes neural stem cell proliferation and neural differentiation via the Wnt/β-catenin signaling pathway in vitro. Mol Med Rep. 2018;17(1):330-335.
|
| [19] |
Lindvall O, Kokaia Z. Stem cells for the treatment of neurological disorders. Nature. 2006;441(7097):1094-1096.
|
| [20] |
Kim H, Cooke MJ, Shoichet MS. Creating permissive microenvironments for stem cell transplantation into the central nervous system. Trends Biotechnol. 2012;30(1):55-63.
|
| [21] |
Dooley D, Vidal P, Hendrix S. Immunopharmacological intervention for successful neural stem cell therapy: new perspectives in CNS neurogenesis and repair. Pharmacol Ther. 2014;141(1):21-31.
|
| [22] |
Sathyan P, Zinn PO, Marisetty AL, et al. Mir-21–Sox2 axis delineates glioblastoma subtypes with prognostic impact. J Neurosci. 2015;35(45):15097-15112.
|
| [23] |
Trohatou O, Zagoura D, Bitsika V, et al. Sox2 Suppression by miR-21 Governs Human Mesenchymal Stem Cell Properties. Oxford University Press; 2014:54-68.
|
| [24] |
Cimadamore F, Amador-Arjona A, Chen C, Huang CT, Terskikh AV. SOX2–LIN28/let-7 pathway regulates proliferation and neurogenesis in neural precursors. Proc Natl Acad Sci USA. 2013;110(32):E3017-E3026.
|
| [25] |
Sekar D, Krishnan R, Panagal M, Sivakumar P, Gopinath V, Basam V. Deciphering the role of microRNA 21 in cancer stem cells (CSCs). Genes Dis. 2016;3(4):277-281.
|
| [26] |
Kalhori MR, Soleimani M, Alibakhshi R, et al. The potential of miR-21 in stem cell differentiation and its application in tissue engineering and regenerative medicine. Stem Cell Rev Rep. 2023;19(5):1232-1251.
|
| [27] |
Mendell JT, Olson EN. MicroRNAs in stress signaling and human disease. Cell. 2012;148(6):1172-1187.
|
| [28] |
Zhu L, Skoultchi AI. Coordinating cell proliferation and differentiation. Curr Opin Genet Dev. 2001;11(1):91-97.
|
| [29] |
Cattaneo E, Mckay R. Proliferation and differentiation of neuronal stem cells regulated by nerve growth factor. Nature.1990;347(6295):762-765.
|
| [30] |
Gao X, Li X, Qian C, et al. MiR-21 functions oppositely in proliferation and differentiation of neural stem/precursor cells via regulating AKT and GSK-3Î2. Cell Mol Biol. 2016;62(12):144-149.
|
| [31] |
Brown G, Hughes PJ, Michell RH. Cell differentiation and proliferation—simultaneous but independent? Exp Cell Res. 2003;291(2):282-288.
|
| [32] |
Pevny LH, Nicolis SK. Sox2 roles in neural stem cells. Int J Biochem Cell Biol. 2010;42(3):421-424.
|
| [33] |
Episkopou V. SOX2 functions in adult neural stem cells. Trends Neurosci. 2005;28(5):219-221.
|
| [34] |
Zhang S, Cui W. Sox2, a key factor in the regulation of pluripotency and neural differentiation. World J Stem Cells. 2014;6(3):305.
|
| [35] |
Johnson CD, Esquela-Kerscher A, Stefani G, et al. The let-7 microRNA represses cell proliferation pathways in human cells. Cancer Res. 2007;67(16):7713-7722.
|
| [36] |
Kumar MS, Erkeland SJ, Pester RE, et al. Suppression of non-small cell lung tumor development by the let-7 microRNA family. Proc Natl Acad Sci USA. 2008;105(10):3903-3908.
|
| [37] |
Zhao C, Sun G, Li S, et al. MicroRNA let-7b regulates neural stem cell proliferation and differentiation by targeting nuclear receptor TLX signaling. Proc Natl Acad Sci USA. 2010;107(5):1876-1881.
|
| [38] |
Masoudi MS, Mehrabian E, Mirzaei H. MiR-21: a key player in glioblastoma pathogenesis. J Cell Biochem. 2018;119(2):1285-1290.
|
| [39] |
Panagal M, Biruntha M, Vidhyavathi R, Sivagurunathan P, Senthilkumar SR, Sekar D. Dissecting the role of miR-21 in different types of stroke. Gene. 2019;681:69-72.
|
RIGHTS & PERMISSIONS
2025 The Author(s). Animal Models and Experimental Medicine published by John Wiley & Sons Australia, Ltd on behalf of The Chinese Association for Laboratory Animal Sciences.
PDF
